Biomarkers in Prediction of AMI
Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)
University of Tartu
250 participants
Oct 14, 2024
INTERVENTIONAL
Conditions
Summary
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
Eligibility
Inclusion Criteria2
- Age 18 years or older
- Initial decision in favour of further diagnostics of mesenteric ischaemia
Exclusion Criteria6
- Age \<18 years
- Consent declined by patient or next of kin (delayed consent)
- Chronic mesenteric ischaemia without an acute event
- Immediate decision for withdrawal of further diagnostics and active treatment
- Referral from another hospital with already established diagnosis of AMI
- AMI diagnosed at surgery without previously having been considered
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Sequential blood samples for diagnostic tests is the only intervention in thei study
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06212921